Symbol: |
LINC00535
|
Description: |
null
|
Location: |
null
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:91
Gene |
Compound |
Gen_sig |
Exp_pattern |
LINC00535 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.014 |
Down |
LINC00535 |
2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide |
0.028 |
Down |
LINC00535 |
NSC 733155 |
0.041 |
Up |
LINC00535 |
Everolimus |
0.044 |
Down |
LINC00535 |
2-(4-morpholinophenylamino)-6-(2,6-dichlorophenyl)-8-methylp yrido[2,3-d]pyrimidin-7(8H)-one |
0.042 |
Up |
LINC00535 |
4,5,6-tribromo-7-(3-N-methylpiperazinyl-2-hydroxypropoxy)-2,3-dihydro-2,2-dimethyl-benzo[b]furan hydrochloride |
0.005 |
Up |
LINC00535 |
Bisarylpurine |
0.012 |
Down |
LINC00535 |
NSC 745455 |
0.034 |
Up |
LINC00535 |
NSC 745624 |
0.035 |
Up |
LINC00535 |
Petriosamine A |
0.043 |
Up |
LINC00535 |
6-chloro-2-(4-methyl-piperazin-1-ylmethyl)-4-phenyl-quinoline-3-carboxylic acid ethyl ester |
0.013 |
Up |
LINC00535 |
AZG |
0.003 |
Up |
LINC00535 |
NSC 83492 |
0.037 |
Up |
LINC00535 |
NSC 90630 |
0.022 |
Up |
LINC00535 |
NSC 90810 |
0.003 |
Up |
Expression pattern: Sensitivity / Resistance
Total:7 Current:6
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:null
SNP |
Gene |
SNP_location |
SNP_allele |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|